Rinath Jeselsohn M.D. Dr Jeselsohn is a medical oncologist and physician scientist whose research work focuses on mechanisms of treatment resistance and tumor progression in hormone receptor positive breast cancer. She is an Assistant Professor of Medicine in the Department of Medical Oncology, Division of Molecular and Cellular Oncology and the Breast Oncology Center at the Dana Farber Cancer Institute. Dr Jeselsohn obtained her M.D. degree from the Hebrew University in Jerusalem. She did her residency in Internal Medicine in the University of Texas SA, Health Science Center and Fellowship in Heme/Onc at Tufts Medical Center. After the completion of her clinical training , she trained in the lab Dr. Myles Brown at the Dana Farber Cancer Institute.
Agostina Nardone Ph.D. Research Associate Agostina received her B.Sc. in Medical Biotechnology, from the University of Federico II in Napoli, Italy and her Ph.Din Life and Earth Sciences from Sannio’s University in Benevento, Italy. Agostina completed a post-doctoral research fellowship at Baylor College of Medicine in Houston where she studied signaling pathways leading to endocrine resistance. Agostina’s research goal is to understand molecular and genetic factors of endocrine resistance in breast cancer. She is utilizing genome-wide CRISPR-based screens and functional assays to identify new vulnerabilities in breast cancer.
Cristina Guarducci Ph.D. Postdoctoral Research Fellow Cristina attended the University of Florence for her undergraduate studies in Cellular and Molecular Biology. She obtained a PhD at the University of Pisa in Clinical Pathology. During her Phd she studied resistance to CDK4/6 inhibitors. At DFCI, she is exoaning her studies on CDK4/6 inhibitors in breast cancer. Cristina is the recipient of Associazione Italiana Ricerca sul Cancro (AIRC) fellowship an American-Italian Cancer Research Foundation award.
Francisco Hermida Prado Ph.D. Postdoctoral Research Fellow Fran completed a Bachelor of Science and Master of Science in Biomedicine at the University of Oviedo, Spain. He then went on to pursue a Ph.D. in Molecular Oncology at the University of Oveido, Spain. His research at DFCI is focused on studying pathways that modulate immune stimuli in breast cancer and approaches to enhance an anti-tumor immune response.
Wen Ma M.D. Visiting Research Fellow Wen received his M.D. degree from the medical school at the Xi'an Jiaotong University Medical School, China. He trained as a breast surgeon and worked as a breast surgeon at the Xijing hospital in Xi'an, China. At DFCI he dedicating his time to breast cancer research. He is studying the combination of endocrine treatment and chemotherapy in hormone receptor positive breast cancer.
Haonan Sun M.S Computational Biology Bioinformatics Analyst Haonan received a Bachelor of Arts in Biology from Grinnel College, Iowa. He then completed a Masters of Science in Computational Biology at Carnegie Mellon University. Haonan has recently joined the lab and is working with the other team members on data analysis.
Shira Sherman M.D. Research Fellow Shira received her medical degree from the Ben Gurion University of the Negev in Israel. Subsequently, she served as a military doctor in the Israel Defense Forces for 5 years. Shira started her residency in Medical Oncology at the Rabin Medical Center in Israel. She is now taking a hiatus from clinical responsibilities and dedicating her time to lab research in breast cancer.